Inventiva SA nas receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Inventiva Sa ADR (IVA)
Inventiva Sa ADR stock price live, this page displays NASDAQ IVA stock exchange data. View the IVA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Inventiva Sa ADR real time stock price chart below.
What Is the Inventiva Sa ADR Stock Price Today?
The Inventiva Sa ADR stock price today is 2.980.
What Is the Stock Symbol for Inventiva Sa ADR?
The stock symbol for Inventiva Sa ADR is "IVA."
What Stock Exchange Does Inventiva Sa ADR Trade On?
Inventiva Sa ADR is listed and trades on the NASDAQ stock exchange.
Is Inventiva Sa ADR a Good Stock to Buy?
Determining whether Inventiva Sa ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IVA quote. (ISIN: US46124U1079)
What Is the Inventiva Sa ADR Stock Price Today?
The Inventiva Sa ADR stock price today is 2.980.
What Is the Stock Symbol for Inventiva Sa ADR?
The stock symbol for Inventiva Sa ADR is "IVA."
What Stock Exchange Does Inventiva Sa ADR Trade On?
Inventiva Sa ADR is listed and trades on the NASDAQ stock exchange.
Is Inventiva Sa ADR a Good Stock to Buy?
Determining whether Inventiva Sa ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IVA quote. (ISIN: US46124U1079)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.950
3.090
52 wk Range
2.820
7.982
IVA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.9503.090
52 wk Range
2.8207.982
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IVA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
15.200
Upside
+410.07%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Inventiva SA nas receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Inventiva SA nas receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Inventiva SA nas receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
12 Buy
0 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 15.200
(+410.07% Upside)
Inventiva Sa ADR Earnings Call Summary for Q2/2026
- Inventiva beat Q2 2026 estimates with EPS of -$0.38 vs. -$0.54 expected and revenue of $6.4M vs. $6.0M forecast; stock fell 2.67% premarket.
- Cash position of EUR 233.9M funds operations through Q2 2027, covering pivotal NATiV3 Phase III MASH trial readout expected Q4 2026.
- Company preparing for potential NDA filing in H1 2027 and U.S. commercial launch in 2028, contingent on positive lanifibranor Phase III data.
- Analyst consensus remains strong buy with price targets of $8.80-$26; investors focused on clinical risk from single-asset dependence on lanifibranor.
- Management emphasized lanifibranor's differentiated dual mechanism targeting metabolic and hepatic MASH drivers; weight gain and edema remain monitored risks.
Last Updated: 2026-09-28, 09:14 a/m
Read Full TranscriptEarnings
Latest Release
Sep 28, 2026
EPS / Forecast
-0.20 / -0.54
Revenue / Forecast
753.43K / 6M
Compare IVA to Peers and Sector
Metrics to compare | IVA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIVAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.6x | −2.7x | −0.3x | |
PEG Ratio | −0.04 | 0.01 | 0.00 | |
Price/Book | 10.9x | 0.8x | 2.6x | |
Price / LTM Sales | 262.6x | 6.9x | 2.9x | |
Upside (Analyst Target) | - | 312.7% | 62.0% | |
Fair Value Upside | Unlock | 5.7% | 9.5% | Unlock |
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Inventiva ADR (IVA) Stock Price Today?
The Inventiva ADR stock price today is 2.980 USD.
What Stock Exchange Does Inventiva ADR Trade On?
Inventiva ADR is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Inventiva ADR?
The stock symbol for Inventiva ADR is "IVA."
What Is the Inventiva ADR Market Cap?
As of today, Inventiva ADR market cap is 728.780M USD.
What Is Inventiva ADR's Earnings Per Share (TTM)?
The Inventiva ADR EPS (TTM) is -1.05.
When Is the Next Inventiva ADR Earnings Date?
Inventiva ADR will release its next earnings report on Nov 23, 2026.
From a Technical Analysis Perspective, Is IVA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Inventiva ADR Stock Split?
Inventiva ADR has split 0 times.
How Many Employees Does Inventiva ADR Have?
Inventiva ADR has 87 employees.
What is the current trading status of Inventiva ADR (IVA)?
As of Oct 20, 2026, Inventiva ADR (IVA) is trading at a price of 2.980 USD, with a previous close of 2.980 USD. The stock has fluctuated within a day range of 2.950 USD to 3.090 USD, while its 52-week range spans from 2.820 USD to 7.982 USD.
What Is Inventiva ADR (IVA) Price Target According to Analysts?
The average 12-month price target for Inventiva ADR is 15.200 USD, with a high estimate of 26 USD and a low estimate of 10 USD. 12 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +410.07% Upside potential.
What Is the IVA After Hours Price?
IVA's last after hours stock price is 3.050 USD, the stock has decreased by 0.070, or 2.350%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.